GEN Acquisition Corp. Announces Extension of its Tender Offers for Genesis Healthcare Corporation's 8% Senior Subordinated Notes
12 July 2007 - 11:59AM
PR Newswire (US)
NEW YORK, July 11 /PRNewswire/ -- GEN Acquisition Corp. ("GEN
Acquisition") announced today that it is extending its previously
announced cash tender offers and consent solicitations with respect
to any and all of the 8% Senior Subordinated Notes due 2013 (CUSIP
Nos. 37184DAC5 and 37184DAA9) (the "8% Notes") and any and all of
the 2.5% Convertible Senior Subordinated Debentures due 2025 (CUSIP
Nos. 37184DAE1 and 37184DAD3) (the "2.5% Notes" and together with
the 8% Notes, the "Notes"), issued by Genesis HealthCare
Corporation ("GHC") (NASDAQ:GHCI). The terms of the tender offers
are amended accordingly. The new Expiration Date for both tender
offers is 5:00 p.m., New York City time, on July 12, 2007, unless
the tender offers are further extended or earlier terminated by GEN
Acquisition at its discretion. The tender offers are being made in
connection with the agreement and plan of merger dated as of
January 15, 2007, as amended, among GEN Acquisition, GHC and GEN
Acquisition's parent, FC-GEN Acquisition, Inc. ("Parent"), that
provides for the merger of GEN Acquisition with and into GHC, with
GHC being the surviving corporation in the merger (the
"Acquisition"). GEN Acquisition and Parent are owned by affiliates
of Formation Capital, LLC and affiliates of JER Partners, which is
the private equity investment group affiliated with J.E. Robert
Company, Inc. The tender offers are being extended to coordinate
the expiration of the tender offers with the closing of the
Acquisition (a condition to the tender offers). GEN Acquisition has
received tenders from holders of 100% of the 8% Notes and 100% of
the 2.5% Notes. The tender offers and consent solicitations are
being made solely on the terms and subject to the conditions set
forth in the Offer to Purchase and Consent Solicitation Statement
dated June 7, 2007, and the accompanying Letter of Transmittal and
Consent, as amended and supplemented by GEN Acquisition's press
releases dated June 20, 2007, June 21, 2007, July 5, 2007 and July
9, 2007 and this press release (the "Tender Offer Documents").
Capitalized terms not otherwise defined in this press release have
the meanings given to them in the Tender Offer Documents. GEN
Acquisition reserves the right to terminate, withdraw or amend the
tender offers and consent solicitations at any time, subject to
applicable law. GEN Acquisition's tender offers are subject to the
conditions set forth in the Tender Offer Documents, including,
without limitation, the consummation of the Acquisition, the
receipt of the financing necessary to pay for the Notes and the
receipt of the requisite consents in accordance with the terms of
the tender offers and consent solicitations. Although it is
currently envisaged that the tender offers will be run
concurrently, each tender offer is a separate and distinct offer.
The timing and other terms and conditions of each tender offer may
be amended with or without corresponding amendments to the other
tender offer. GEN Acquisition has retained UBS Investment Bank to
act as Dealer Manager in connection with the tender offers and
consent solicitations. Questions about the tender offers and
consent solicitations may be directed to the Liability Management
Group of UBS Investment Bank at (888) 722-9555 x3374210 (toll free)
or (203) 719-4210 (collect). Copies of the Tender Offer Documents
and other related documents may be obtained from Innisfree M&A
Incorporated, the information agent for the tender offers and
consent solicitations, at (888) 750-5834 (noteholders call
toll-free) or (212) 750-5833 (banks and brokers call collect). The
tender offers and consent solicitations are being made solely by
means of the Tender Offer Documents. Under no circumstances shall
this press release constitute an offer to purchase or the
solicitation of an offer to sell the Notes or any other securities
of GHC. It also is not a solicitation of consents to the proposed
amendments to the indentures. No recommendation is made as to
whether holders of the Notes should tender their Notes or give
their consent. This press release does not constitute an offer to
sell or the solicitation of an offer to buy any security and shall
not constitute an offer, solicitation or sale of any securities in
any jurisdiction in which such offering, solicitation or sale would
be unlawful. Forward Looking Statements Certain statements in this
press release are forward-looking statements within the meaning of
Section 27A of the Securities Act of 1933, as amended and Section
21E of the Securities Exchange Act of 1934, as amended. Forward
looking statements may be identified by the words "believe,"
"expect," "anticipate," "project," "plan," "estimate," "will" or
"intend" and similar expressions. The forward-looking statements
contained herein reflect our current views with respect to future
events and are based on our currently available financial, economic
and competitive data and on current business plans. Actual results
could vary materially depending on risks and uncertainties that may
affect GEN Acquisition's business and operations and other factors.
These forward-looking statements speak only as of the date on which
the statements were made and we undertake no obligation to publicly
update or review any forward-looking statement, whether as a result
of new information, future developments or otherwise, except as
otherwise required by law. About Formation and JER Formation
Capital is a private equity firm in the senior housing and long-
term care industry. Over the past five years Formation Capital has
completed over $1.5 billion of acquisitions in the sector and
provides asset management services to over 250 facilities
nationwide. For more information on Formation Capital, please visit
http://www.formationcapital.com/. JER Partners is the private
equity investment arm of J.E. Robert Companies, a real estate
investment management company with more than 25 years of experience
in sourcing, underwriting and managing a broad spectrum of real
estate equity investments and debt products in North America and
Europe. JER has completed over $1.1 billion of acquisitions in the
senior housing sector. JER's primary investments are in office,
hospitality, retail, multi-family, healthcare-related real estate
and industrial properties. Other areas of investment include
commercial mortgage-backed securities ("CMBS") and mezzanine
financing. For more information on JER, please visit
http://www.jer.com/. DATASOURCE: GEN Acquisition Corp. CONTACT:
Innisfree M&A Incorporated, Banks and Brokers Call Collect,
+1-212-750-5833, All Others Call Toll Free, +1-888-750-5834 Web
site: http://www.formationcapital.com/ http://www.jer.com/
Copyright
Genesis Healthcare (NASDAQ:GHCI)
Historical Stock Chart
From Oct 2024 to Nov 2024
Genesis Healthcare (NASDAQ:GHCI)
Historical Stock Chart
From Nov 2023 to Nov 2024